Pierre Kemula joined Agomab in 2024. Previously, he was the Chief Financial Officer CureVac. During his 8-year tenure, he successfully contributed to the financing of the Company with its NASDAQ IPO and several follow-on offerings. In the years before, Pierre was the CFO of Pixium Vision where he led the company’s listing on Euronext in Paris, and Vice President of Corporate Finance, Treasury and Financial Markets at Ipsen. Earlier in his career, Mr. Kemula worked with major strategy consulting firms (Roland Berger, Bossard Consultants and Gemini Consulting). He holds a Bachelor of Science in Management Sciences from the London School of Economics (LSE) in the United Kingdom.